Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CCR5 (Leronlimab Biosimilar) antibody (Biotin)

This Humanized Monoclonal antibody specifically detects CCR5 (Leronlimab Biosimilar) in FACS. It exhibits reactivity toward Human.
Catalog No. ABIN7850308
$340.25
Plus shipping costs $50.00
Shipping to: United States
Delivery in 25 to 32 Business Days

Quick Overview for Recombinant CCR5 (Leronlimab Biosimilar) antibody (Biotin) (ABIN7850308)

Target

CCR5 (Leronlimab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 1
  • 1
  • 1
Humanized

Clonality

  • 2
  • 1
Monoclonal

Conjugate

  • 3
This CCR5 (Leronlimab Biosimilar) antibody is conjugated to Biotin

Application

  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Grade

Research Grade
  • Purpose

    Biotinylated Anti-CCR5(leronlimab biosimilar) mAb

    Isotype

    IgG4, S228P, kappa
  • Application Notes

    Flow Cyt 1:100

    Comment

    Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Please see Certificate of Analysis for specific instructions of reconstitution.

    Buffer

    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.

    Expiry Date

    12 months
  • Target

    CCR5 (Leronlimab Biosimilar)

    Alternative Name

    leronlimab Biosimilar

    Target Type

    Biosimilar

    Background

    Synonyms Target:CKR5, CCR-5, CD195, CKR-5, CCCKR5, CMKBR5, IDDM22, CC-CKR-5
    Synonyms Antibody:PRO 140, HuPRO-140, PRO-140

    UniProt

    P51681
You are here:
Chat with us!